Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model.
Miyamoto R, Takigawa H, Yuge R, Shimizu D, Ariyoshi M, Otani R, Tsuboi A, Tanaka H, Yamashita K, Hiyama Y, Urabe Y, Ishikawa A, Sentani K, Oka S. Miyamoto R, et al. Among authors: hiyama y. Exp Mol Pathol. 2024 May 2;137:104896. doi: 10.1016/j.yexmp.2024.104896. Online ahead of print. Exp Mol Pathol. 2024. PMID: 38703552 Free article.
Fourth national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from patients with complicated urinary tract infections.
Kobayashi K, Takahashi S, Yasuda M, Miyazaki J, Wada K, Matsumoto M, Hayami H, Yamamoto S, Kiyota H, Sato J, Matsumoto T, Hasegawa N, Kobayashi I, Masumori N, Kimura T, Yamada H, Nakagawa T, Kaneko T, Matsumoto K, Fujimura T, Kamei J, Ishikawa K, Fujimoto K, Nakai Y, Shigemura K, Sadahira T, Hinata N, Kitano H, Yamashita M, Yasufuku T, Komeda H, Hiyama Y, Takahashi Y, Kanamaru S, Murakami M, Arakawa S, Yamada D, Mita K, Hamasuna R, Tanaka K, Matsukawa M, Takaoka E, Shigeta M, Takenaka T, Nishino M, Ishitoya S, Hayakawa S, Okumura K, Ueda M. Kobayashi K, et al. Among authors: hiyama y. J Infect Chemother. 2024 Apr 6:S1341-321X(24)00108-9. doi: 10.1016/j.jiac.2024.03.024. Online ahead of print. J Infect Chemother. 2024. PMID: 38588797
Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
Shindo T, Hashimoto K, Takahashi A, Miyamoto S, Kunishima Y, Sato S, Fukuta F, Hiyama Y, Takayanagi A, Kato R, Wanifuchi A, Ueki Y, Okada M, Adachi H, Kobayashi KO, Tanaka T, Masumori N; Sapporo Medical University Urologic Oncology Consortium. Shindo T, et al. Among authors: hiyama y. Anticancer Res. 2024 Mar;44(3):1271-1279. doi: 10.21873/anticanres.16922. Anticancer Res. 2024. PMID: 38423657
Pazopanib-induced enteritis in a patient with renal cell carcinoma.
Ariyoshi M, Hayashi R, Takasago T, Yamashita K, Hiyama Y, Yuge R, Urabe Y, Ueno Y, Shimamoto F, Oka S. Ariyoshi M, et al. Among authors: hiyama y. Clin J Gastroenterol. 2024 Feb 26. doi: 10.1007/s12328-024-01919-w. Online ahead of print. Clin J Gastroenterol. 2024. PMID: 38407743
Predictive factors for esophageal stenosis in patients receiving prophylactic steroid therapy after endoscopic submucosal dissection for esophageal squamous cell carcinoma.
Mizuno J, Urabe Y, Oka S, Konishi H, Ishibashi K, Fukuhara M, Tanaka H, Tsuboi A, Yamashita K, Hiyama Y, Kotachi T, Takigawa H, Yuge R, Hiyama T, Tanaka S. Mizuno J, et al. Among authors: hiyama y. BMC Gastroenterol. 2024 Jan 20;24(1):41. doi: 10.1186/s12876-024-03135-9. BMC Gastroenterol. 2024. PMID: 38245690 Free PMC article.
204 results